Activation of coagulation system in dilated cardiomyopathy: Comparison of patients with and without left ventricular thrombus

Coronary Artery Disease

Volumn 15, Issue 5, 2004, Pages 265-268

  Erbay, Ali Riza ^a   Turhan, Hasan ^b   Aksoy, Yuksel ^b   Senen, Kubilay ^a   Yetkin, Ertan ^b  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b INONU UNIVERSITY   (Turkey)

Author keywords

Coagulation activation; Dilated cardiomyopathy

Indexed keywords

ALPHA 2 ANTIPLASMIN; BETA THROMBOGLOBULIN; D DIMER; FIBRIN; FIBRINOPEPTIDE A; MOLECULAR MARKER; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOCYTE FACTOR;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD LEVEL; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; HEART VENTRICLE THROMBOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THROMBOCYTE ACTIVATION; THROMBUS;

ADULT; ANTITHROMBIN III; BETA-THROMBOGLOBULIN; BIOLOGICAL MARKERS; BLOOD COAGULATION; CARDIOMYOPATHY, DILATED; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOPEPTIDE A; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; PEPTIDE HYDROLASES; PLATELET ACTIVATION; PLATELET FACTOR 4; STROKE VOLUME; THROMBIN; THROMBOSIS; TURKEY;

EID: 4043137326     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mca.0000135596.54871.6f     Document Type: Article

References (21)

1. Fuster V, Gersh BJ, Giuliani ER, Tajik AJ, Brandenburg RO, Frye RL. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1981; 47:525-530.
2. Wilensky RL, Jung SC. Thromboembolism in patients with decreased left ventricular function: incidence, risk, and treatment. J Cardiovasc Risk 1995; 2:91-96.
3. Roberts WC, Siegel RJ, McManus BM. Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol 1987; 60:1340-1355.
4. Gottdiener JS, Gay JA, Van Voorhees L, DiBianco R, Fletcher RD. Frequencyt and embolic potential of left ventricular thrombus in dilated cardiomyopathy: assessment of two-dimentional echocardiography. Am J Cardiol 1983; 52:1281-1285.
5. Siostrzonek P, Koppensteiner R, Gossinger H, Zangeneh M, Heinz G, Kreiner G, et al. Hemodynamic and hemorrheologic determinants of left atrial spontaneous echo contrast and thrombus formation in patients with idiopathic dilated cardiomyopathy. Am Heart J 1993; 125:430-434.
6. Asinger RW, Mikell FL, Elsperger J, Hodges M. Incidence of left ventricular thrombosis after acute transmural myocardial infarction: serial evaluation by two-dimensional echocardiography. N Engl J Med 1981; 305:297-302.
7. Goodwin JF, Oakley CM. The cardiomyopathies. Br Heart J 1972; 34:545-552.
8. Johnson RA, Palacios I. Dilated cardiomyopathies of the adult. N Engl J Med 1982; 307:1051-1058.
9. Segal JP, Stapleton JP, McClellan JR, Waller BF, Harvery WP. Idiopathic cardiomyopathy: clinical features, prognosis and therapy. Curr Prob Cardiol 1978; 3:1-48.
10. Massumi RA, Rios JC, Gooch AS, Nutter D, Devita VT, Datlow DW. Primary myocardial disease: report of fifty cases and review of the subject. Circulation 1965; 31:19-41.
11. Sharma ND, McCullough PA, Philbin EF, Weaver WD. Left ventricular thrombus and subsequent thromboembolism in patients with severe systolic dysfunction. Chest 2000; 117:314-320.
12. Yetkin E, Erbay AR, Ayaz S, Ileri M, Yetkin G, Çehreli S, et al. Predictors of left ventricular thrombus formation in patients with anterior myocardial infarction: role of activated protein C resistance. Coron Artery Dis 2001; 11:269-272.
13. Erbay AR, Turhan H, Senen K, Yetkin F, Ayaz S, Kara F, et al. Predictors of left ventricular thrombus formation in patients with dilated cardiomyopathy: role of activated protein C resistance. Coron Artery Dis 2004; 15:107-110.
14. Yamamato K, Ikeda U, Furuhashi K, Irokawa M, Nakayama T, Shimada K. The coagulation system is activated in idiopathic cardiomyopathy. J Am Coll Cardiol 1995; 25:1634-1640.
15. Weidinger F, Glogar D, Sochor H, Sinzinger H. Platelet survival in patients with dilated cardiomyopathy. Thromb Haemost 1991; 66:400-405.
16. Maze SS, Kotler MN, Parry WR. Flow characteristics in dilated left ventricle with thrombus: qualitative and quantitative Doppler analysis. J Am Coll Cardiol 1989; 13:873-881.
17. Delemarre BJ, Bot H, Visser CA, DeKoning H, Dunning AJ. Thrombus formation after acute myocardial infarction predicted by left ventricular spatial flow pattern [abstract]. J Am Coll Cardiol 1988; 11:175A.
18. Yetkin E, Erbay AR, Turhan H, Ileri M, Ayaz S, Atak R, et al. Decreased platelet activation and endothelial dysfunction after percutaneous mitral balloon valvuloplasty. Int J Cardiol 2003; 91:221-225.
19. Asakura H, Hifumi S, Jokaji H, Saito M, Kumabashiri I, Uotani C, et al. Prothrombin fragment F1 + 2 and thrombin-anthithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation. Blood Coagul Fibrinolysis 1992; 3:469-473.
20. Jafri SM, Ozawa T, Mammen E, Levine TB, Johnson C, Goldstein S. Platelet function, thrombin and fibrinolytic activity in patients with heart failure. Eur Heart J 1993; 14:205-212.
21. Roberts WC, Siegel RJ, McManus BM. Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol 1987; 60:134-135.